The Long Run with Luke Timmerman cover image

Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery

The Long Run with Luke Timmerman

CHAPTER

Biotec - What's Next for Biotec?

Raymond Sounotobit is the founder and CEO of a biotechnology company. The company has two molecules in the clinic right now, with plans to have another one later this year or early next year. "My measure of success for shote number of patients that we treat" will be his metric for success," he says.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner